First LSD Study In More Than 40 Years Shows Reduced Anxiety In Terminally Ill

New York Daily News reports that results published in the <i>Journal of Nervous and Mental Disease</i> indicate that LSD-assisted psychotherapy can help reduce anxiety in subjects diagnosed with advanced-stage illness. The study notes the positive outcome of the study, explaining, “Those who received full dosages of LSD reported their feelings of anxiety dropped by about 20%.”

Originally appearing here.

Dropping acid can allay angst in those suffering terminal illness, a new survey has exposed.

Noting that legalized used of LSD by U.S. psychiatrists slammed to a halt in 1966 after the mind-altering drug became popular as a recreational narcotic, the new survey reported favorable results among advance-staged cancer patients in Switzerland.

The findings published this week in The Journal of Nervous and Mental Disease detail the first controlled study of LSD-assisted psychotherapy in more than 40 years.

Anxiety, depression, chronic pain and emotional suffering are serious problems for the dying, the survey said.

Two double-blind groups were used. Most had no prior experience with taking the hallucinogen.

Those who received full dosages of LSD reported their feelings of anxiety dropped by about 20%.

Though the study group was too small to render conclusive results, its findings were considered worth further research, administrators of the study said.